Stock Research: Abbott Laboratories

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Abbott Laboratories

NYSE:ABT US0028241000
98
  • Value
    75
  • Growth
    63
  • Safety
    Safety
    74
  • Combined
    98
  • Sentiment
    72
  • 360° View
    360° View
    98
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a broad line of healthcare products. It operates in the Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices industries. The company serves people in over 160 countries. In the last fiscal year, the company had a market cap of $228,771 million, profits of $23,306 million, and revenue of $41,950 million with 114000 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 98 (better than 98% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Abbott Laboratories are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Abbott Laboratories. The consolidated Value Rank has an attractive rank of 74, which means that the share price of Abbott Laboratories is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 74% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 63, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 75. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 72. ...read more

more
Index
Dividends USA
Diversity USA
Recycling
D.J. US Medical Equipment
S&P 500
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
74 59 62 87
Growth
63 55 49 45
Safety
Safety
75 81 42 30
Sentiment
72 90 83 95
360° View
360° View
98 98 86 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
51 69 62 64
Opinions Change
48 49 48 50
Pro Holdings
n/a 96 83 97
Market Pulse
91 97 78 78
Sentiment
72 90 83 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
74 59 62 87
Growth
63 55 49 45
Safety Safety
75 81 42 30
Combined
98 91 56 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
50 35 44 54
Price vs. Earnings (P/E)
33 33 35 51
Price vs. Book (P/B)
34 35 31 43
Dividend Yield
96 96 98 98
Value
74 59 62 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
37 45 17 7
Profit Growth
44 49 30 70
Capital Growth
76 42 73 36
Stock Returns
83 69 67 81
Growth
63 55 49 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
62 58 44 41
Refinancing
19 17 9 3
Liquidity
81 95 86 76
Safety Safety
75 81 42 30

Similar Stocks

Discover high‑ranked alternatives to Abbott Laboratories and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.